The following pages link to lamotrigine (Q410346):

Displaying 50 items.

• World Health Organization Model List of Essential Medicines (Q37155) (← links)
• epilepsy (Q41571) (← links)
• bipolar disorder (Q131755) (← links)
• migraine (Q133823) (← links)
• anxiety (Q154430) (← links)
• mood disorder (Q188638) (← links)
• post-traumatic stress disorder (Q202387) (← links)
• borderline personality disorder (Q208166) (← links)
• tick-borne encephalitis (Q326663) (← links)
• temporal lobe epilepsy (Q616667) (← links)
• trigeminal neuralgia (Q1132120) (← links)
• neurological disorder (Q3339235) (← links)
• focal epilepsy (Q7140388) (← links)
• visual epilepsy (Q18554191) (← links)
• Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials (Q22241689) (← links)
• Lamotrigine for chronic neuropathic pain and fibromyalgia in adults (Q24201979) (← links)
• Lamotrigine adjunctive therapy for refractory generalized tonic-clonic seizures (Q24235599) (← links)
• Lamotrigine for acute and chronic pain (Q24236694) (← links)
• Lamotrigine add-on for refractory generalized tonic-clonic seizures (Q24240784) (← links)
• Lamotrigine for schizophrenia (Q24243946) (← links)
• Lamotrigine for acute and chronic pain (Q24244175) (← links)
• Lamotrigine for schizophrenia (Q24244202) (← links)
• Lamotrigine versus carbamazepine monotherapy for epilepsy (Q24244885) (← links)
• Lamotrigine for acute and chronic pain (Q24245369) (← links)
• Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents (Q24245943) (← links)
• Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents (Q24247993) (← links)
• Guidelines for treating epilepsy in the age of felbamate, vigabatrin, lamotrigine, and gabapentin. (Q24514895) (← links)
• Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy (Q24630240) (← links)
• Publication bias and the pharmaceutical industry: the case of lamotrigine in bipolar disorder (Q24643545) (← links)
• The role of lamotrigine in the management of bipolar disorder (Q24658110) (← links)
• The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial (Q24676550) (← links)
• The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects (Q24678717) (← links)
• Lamotrigine add-on for drug-resistant partial epilepsy (Q26471446) (← links)
• Lamotrigine effects on breastfed infants (Q26777649) (← links)
• Management of bipolar depression with lamotrigine: an antiepileptic mood stabilizer (Q26777966) (← links)
• Advantages and problems with pregnancy registries: observations and surprises throughout the life of the International Lamotrigine Pregnancy Registry (Q26858860) (← links)
• Safety profile of lamotrigine in overdose (Q28066916) (← links)
• Lamotrigine monotherapy in children with epilepsy: a systematic review (Q28071282) (← links)
• Maternal and Fetal Outcomes After Lamotrigine Use in Pregnancy: A Retrospective Analysis from an Urban Maternal Mental Health Centre in New Zealand (Q28079787) (← links)
• A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group (Q28139401) (← links)
• Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis (Q28140826) (← links)
• Evaluation of antiepileptic activity of aspirin in combination with newer antiepileptic lamotrigine in mice (Q28166464) (← links)
• Actions of sipatrigine, 202W92 and lamotrigine on R-type and T-type Ca2+ channel currents (Q28198378) (← links)
• Inhibition of N-type calcium currents by lamotrigine in rat amygdalar neurones (Q28235930) (← links)
• Newer antiepileptic drugs: gabapentin, lamotrigine, felbamate, topiramate and fosphenytoin (Q28262752) (← links)
• Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine (Q28269848) (← links)
• UGT2B7_-161C>T polymorphism is associated with lamotrigine concentration-to-dose ratio in a multivariate study (Q28275521) (← links)
• When treating patients with schizophrenia, what clinical points should be considered if lamotrigine is chosen to augment clozapine? (Q28345712) (← links)
• Influence of cirrhosis on lamotrigine pharmacokinetics (Q28367489) (← links)
• Fulminant hepatic failure induced by lamotrigine (Q28367927) (← links)